“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The FDA has released the guidance document “Drug Products, Including Biological Products, that Contain Nanomaterials – Guidance for Industry.” It finalizes the draft guidance issued…
In April of 2021, the FDA issued its first Notice of Noncompliance to a company failing to submit required summary results information to ClinicalTrials.gov. This…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…
The National Human Genome Research Institute (NHGRI) started celebrating DNA Day annually on April 25th, 2003 to provide students, educators, and others with resources to…
“On Campus with CITI Program” is a biweekly podcast launched in January 2022 and hosted by Darren Gaddis, Assistant Director of Content and Education at…
The NIH Office of Laboratory Animal Welfare (OLAW) is seeking public input on flexibilities that IACUCs may consider when conducting semiannual program reviews as a…
“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…
The FDA has released a draft guidance document, “Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft…
The FDA has published the guidance document, “E8(R1) General Considerations for Clinical Studies,” to assist those that design clinical studies by outlining the internationally accepted…
The U.S. Food and Drug Administration (FDA) has resumed its unannounced foreign inspections program in India, yet it remains paused in China due to COVID-19…
